CoS


Journal

RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657

Informations de publication

Date de publication:
05 Jul 2024
Historique:
received: 31 05 2024
accepted: 28 06 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

Cardiovascular diseases caused by atherosclerosis (AS) seriously damage human health. Nano-photothermal technology has been proven to inhibit the development of vascular inflammation by inhibiting the proliferation of inflammatory macrophages. However, photothermal therapy can inhibit the enrichment of AS macrophages in the early stage, but the inhibitory effect is insufficient in the later stage. Herein, we designed and prepared CoS

Identifiants

pubmed: 38974227
doi: 10.1039/d4ra04006f
pii: d4ra04006f
pmc: PMC11224947
doi:

Types de publication

Journal Article

Langues

eng

Pagination

21241-21249

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There is no conflict of interest to declare.

Auteurs

Ran Lu (R)

Department of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004 Anhui China.

Zaiman Ge (Z)

Department of General Surgery, Baoshan People's Hospital Baoshan 678000 Yunnan China GZM15887672801@163.com.

Zeyu Guan (Z)

Department of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004 Anhui China.

Yong Sun (Y)

Department of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004 Anhui China.
Department of General Surgery, Baoshan People's Hospital Baoshan 678000 Yunnan China GZM15887672801@163.com.

Xiaogao Wang (X)

Department of Vascular Surgery, The First Affiliated Hospital of Bengbu Medical University Bengbu 233004 Anhui China.

Bing Liu (B)

Department of Vascular Surgery, The Affiliated Hospital of Qingdao University Qingdao 266000 Shandong China qyfyliubing@163.com.

Classifications MeSH